Logosoma
1 known investors
Logosoma provides speech and language therapy (logopedics) for children and adults, treating articulation, language development, voice, fluency, and swallowing disorders as well as neurological conditions such as aphasia, dysarthria, and Parkinson-related impairments. Treatment is offered in its practices, via teletherapy, and on-site in daycare centers, clinics, and senior care facilities in Germany, accepting statutory and private insurance as well as self-payers.
Digital HealthHealthtechWellness & Fitness